(Q36299916)

13 August 2017

1 reference

title

Molecular classification and biomarker discovery in papillary thyroid carcinoma (English)

1 reference

13 August 2017

0 references

1

1 reference

13 August 2017

publication date

1 November 2005

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

927-946

1 reference

Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

c‐Met expression in tall cell variant papillary carcinoma of the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Morules in cribriform-morular variant of papillary thyroid carcinoma: Immunohistochemical characteristics and distinction from squamous metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

The somatic effects of exposure to atomic radiation: the Japanese experience, 1947-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Health effects from fallout

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicomorphologic characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Familial nonmedullary thyroid neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Distinction Between Papillary Thyroid Hyperplasia and Papillary Thyroid Carcinoma by Immunohistochemical Staining for Cytokeratin 19, Galectin-3, and HBME-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Minireview: GNAS: normal and abnormal functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

TSH receptor status of thyroid neoplasms--TaqMan RT-PCR analysis of archival material

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Real-time quantitative analysis of E-cadherin expression in ret/PTC-1-activated thyroid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Multiple signaling pathways converge on beta-catenin in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Diagnostic utility of cytokeratin 19 expression in multinodular goiter with papillary areas and papillary carcinoma of thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

p53 mutation heterogeneity in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Control of MAP kinase signaling to the nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

The RET proto-oncogene: a molecular therapeutic target in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Ret/PTC chimeric transcripts in an Irish cohort of sporadic papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

RET and NTRK1 proto-oncogenes in human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

H-ras protooncogene mutations in human thyroid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Activators and effectors of ras p21 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Prevalence of activating ras mutations in morphologically characterized thyroid nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

A genome-based strategy uncovers frequent BRAF mutations in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

High frequency of BRAF mutations in nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Autonomously functioning thyroid nodules are not associated with BRAF mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

BRAF T1796A transversion mutation in various thyroid neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Molecular pathobiology of thyroid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

The biology and clinical relevance of the PTEN tumor suppressor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Treatment of thyroid cancer with histone deacetylase inhibitors and peroxisome proliferator-activated receptor-gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Human calgizzarin; one colorectal cancer-related gene selected by a large scale random cDNA sequencing and northern blot analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Predicting the clinical status of human breast cancer by using gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Absence of a specific radiation signature in post-Chernobyl thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Viral mediated gene therapy for the management of metastatic thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Dendritic cell vaccination: new hope for the treatment of metastasized endocrine malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Redifferentiation therapy in advanced thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.6.927

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

21 January 2018

2 references

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1172/JCI200522758

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1172/JCI22758

Identifiers

DOI

10.1586/14737159.5.6.927

1 reference

13 August 2017

1 reference